202 related articles for article (PubMed ID: 27088930)
1. Local antimicrobial, protease and cytokine defense systems in psoriatic skin.
Sidhom E; Pilmane M; Kisis J
Indian J Dermatol Venereol Leprol; 2016; 82(3):284-91. PubMed ID: 27088930
[TBL] [Abstract][Full Text] [Related]
2. Dynamic alteration of human beta-defensin 2 localization from cytoplasm to intercellular space in psoriatic skin.
Huh WK; Oono T; Shirafuji Y; Akiyama H; Arata J; Sakaguchi M; Huh NH; Iwatsuki K
J Mol Med (Berl); 2002 Oct; 80(10):678-84. PubMed ID: 12395153
[TBL] [Abstract][Full Text] [Related]
3. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
Oxholm A
APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
[TBL] [Abstract][Full Text] [Related]
4. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities in cytokine secretion from mesenchymal stem cells in psoriatic skin lesions.
Liu R; Yang Y; Yan X; Zhang K
Eur J Dermatol; 2013; 23(5):600-7. PubMed ID: 24135516
[TBL] [Abstract][Full Text] [Related]
6. Ustekinumab improves psoriasis-related gene expression in noninvolved psoriatic skin without inhibition of the antimicrobial response.
Baerveldt EM; Onderdijk AJ; Kurek D; Kant M; Florencia EF; Ijpma AS; van der Spek PJ; Bastiaans J; Jansen PA; van Kilsdonk JW; Laman JD; Prens EP
Br J Dermatol; 2013 May; 168(5):990-8. PubMed ID: 23278632
[TBL] [Abstract][Full Text] [Related]
7. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
[TBL] [Abstract][Full Text] [Related]
8. Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway.
Balato A; Schiattarella M; Di Caprio R; Lembo S; Mattii M; Balato N; Ayala F
J Eur Acad Dermatol Venereol; 2014 Aug; 28(8):1016-24. PubMed ID: 24033358
[TBL] [Abstract][Full Text] [Related]
9. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
Markham T; Mullan R; Golden-Mason L; Rogers S; Bresnihan B; Fitzgerald O; Fearon U; Veale DJ
J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
[TBL] [Abstract][Full Text] [Related]
10. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.
Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC
Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564
[TBL] [Abstract][Full Text] [Related]
11. Serum IL-33 levels are increased in patients with psoriasis.
Mitsui A; Tada Y; Takahashi T; Shibata S; Kamata M; Miyagaki T; Fujita H; Sugaya M; Kadono T; Sato S; Asano Y
Clin Exp Dermatol; 2016 Mar; 41(2):183-9. PubMed ID: 25976154
[TBL] [Abstract][Full Text] [Related]
12. Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β.
Chen JQ; Man XY; Li W; Zhou J; Landeck L; Cai SQ; Zheng M
Cell Biochem Biophys; 2013 Jul; 66(3):523-8. PubMed ID: 23283814
[TBL] [Abstract][Full Text] [Related]
13. Tissue-engineered human psoriatic skin supplemented with cytokines as an in vitro model to study plaque psoriasis.
Pouliot-Bérubé C; Zaniolo K; Guérin SL; Pouliot R
Regen Med; 2016 Sep; 11(6):545-57. PubMed ID: 27513102
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of psoriatic plaques and perilesional skin in psoriasis vulgaris patients: A pilot study.
Morar II; Tabăran FA; Mocan T; Jianu EM; Orăsan MS; Pop AD; Orăsan RI
Exp Ther Med; 2019 Aug; 18(2):888-894. PubMed ID: 31384319
[TBL] [Abstract][Full Text] [Related]
15. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.
Nickoloff BJ; Karabin GD; Barker JN; Griffiths CE; Sarma V; Mitra RS; Elder JT; Kunkel SL; Dixit VM
Am J Pathol; 1991 Jan; 138(1):129-40. PubMed ID: 1702929
[TBL] [Abstract][Full Text] [Related]
16. Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.
Günther C; Blau K; Förster U; Viehweg A; Wozel G; Schäkel K
Exp Dermatol; 2013 Aug; 22(8):535-40. PubMed ID: 23879812
[TBL] [Abstract][Full Text] [Related]
17. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
18. Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3.
Yang L; Li B; Dang E; Jin L; Fan X; Wang G
J Dermatol Sci; 2016 Feb; 81(2):85-92. PubMed ID: 26627723
[TBL] [Abstract][Full Text] [Related]
19. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G
J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between interleukin 6 and interleukin 1 levels in psoriatic lesional skin.
Takematsu H; Tagami H
Tohoku J Exp Med; 1994 Mar; 172(3):243-52. PubMed ID: 8073436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
